Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Lucinda J. Van Anglen"'
Autor:
Richard L. Hengel, Claudia P. Schroeder, Jinhee Jo, Timothy E. Ritter, Ramesh V. Nathan, Anne J. Gonzales-Luna, Engels N. Obi, Ryan J. Dillon, Lucinda J. Van Anglen, Kevin W. Garey
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-6 (2022)
Abstract Background Clostridioides difficile infection (CDI) is associated with high recurrence rates impacting health-related quality of life (HrQOL). However, patient-reported data are lacking particularly in the outpatient setting. We assessed cha
Externí odkaz:
https://doaj.org/article/07dc502960f347a0b814aa9c7e96e398
Publikováno v:
Open Forum Infectious Diseases. 10
Background Ceftolozane/tazobactam (C/T) is indicated for the treatment of complicated intra-abdominal infection (IAI), complicated urinary tract infection (UTI), and hospital-acquired/ventilator-associated bacterial pneumonia caused by susceptible ba
Autor:
Ramesh V Nathan, Brian S Metzger, Jorge R Bernett, John S Adams, Richard L Hengel, Rishi Bhattacharyya, Claudia P Schroeder, Kimberly A Couch, Lucinda J Van Anglen
Publikováno v:
Open Forum Infectious Diseases. 9
Background Infections with extended-spectrum β-lactamase (ESBL)-producing pathogens present treatment challenges with higher costs of care. Hospitalized patients (pts) with ESBL infections often require outpatient antimicrobial therapy (OPAT) follow
Publikováno v:
Open Forum Infectious Diseases. 9
Background Omadacycline (OMC) is approved for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. Real-world data on the use of OMC are limited. We present a multicenter observational review
Autor:
Clifford P Martin, Thomas K Sleweon, Quyen Luu, Richard C Prokesch, Robin H Dretler, Barry Statner, Kent J Stock, Claudia P Schroeder, Lucinda J Van Anglen
Publikováno v:
Open Forum Infectious Diseases. 9
Background Outpatient parenteral antimicrobial therapy (OPAT) has been shown to be safe and effective for self-administration but can lead to non-adherence without supervision. A physician office infusion center (POIC) with pharmacy services provides
Publikováno v:
Open Forum Infectious Diseases. 9
Background AKI is a complication of intravenous vancomycin (VAN) occurring in up to 43% of patients (pts) during hospitalization. Data on AKI in pts receiving VAN through outpatient parenteral antimicrobial therapy (OPAT) are limited. There is sugges
Autor:
Claudia P. Schroeder, Richard L. Hengel, Ramesh V. Nathan, Timothy E. Ritter, Engels N. Obi, Chris Lancaster, Lucinda J. Van Anglen, Kevin W. Garey
Publikováno v:
Anaerobe. 77
Patients with Clostridioides difficile infection (CDI) who receive treatment at outpatient infusion centers (OICs) pose a risk for spore transmission. We investigated C. difficile contamination in the environment of CDI and non-CDI patients and evalu
Autor:
Timothy E. Ritter, Harry E. Sarles, Annette E. Whitney, Dawn N. Kim-Romo, Lucinda J. Van Anglen
Publikováno v:
American Journal of Gastroenterology. 117:e1056-e1056
Publikováno v:
American Journal of Gastroenterology. 117:e1122-e1122
Autor:
Richard L, Hengel, Claudia P, Schroeder, Jinhee, Jo, Timothy E, Ritter, Ramesh V, Nathan, Anne J, Gonzales-Luna, Engels N, Obi, Ryan J, Dillon, Lucinda J, Van Anglen, Kevin W, Garey
Publikováno v:
Journal of patient-reported outcomes. 6(1)
Clostridioides difficile infection (CDI) is associated with high recurrence rates impacting health-related quality of life (HrQOL). However, patient-reported data are lacking particularly in the outpatient setting. We assessed changes in HrQOL over t